Esperite N.V. (ESP) with CryoSave contributes to treating a 9 year old child with Thalassemia Major in Switzerland

April 25, 2017 Group News
shutterstock_75799198

CryoSave confirms the importance of cord blood stem cells in regenerative medicine.

Last week, CryoSave released a cord blood stem cell unit from the state of the art laboratory in Geneva for the clinical treatment of a young boy who suffers from thalassemia major. The 9 year old patient will receive an allogeneic transplant in Switzerland of the cord blood stem cells from his now 2 year old brother.

Zutphen, The Netherlands – 25 April 2017

read more

Cryo-Save Switzerland receives national accreditation for safe procedures

September 6, 2011 Group News

Cryo-Save Switzerland was positively reviewed by Swissmedic, Switzerland’s government agency for therapeutic products. The received accreditation confirms Cryo-Save’s continuous efforts to deliver high quality, and safe and effective procedures while collecting, processing and preserving stem cells from umbilical cord and cord blood.

read more

EN – Announcement of milestone payment for storing umbilical cord tissue in Serbia and launch in Switzerland

May 17, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, announced today the milestone payment of €500,000 as a result of obtaining permission by the competent authorities to start the collection, processing and storing of umbilical cord tissue in Serbia.

read more

NL – Mijlpaal betaling voor de opslag van navelstrengweefsel in Servië en de start in Zwitserland

May 17, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’ of ‘de Groep’), de toonaangevende internationale familie stamcelbank, kondigt vandaag een mijlpaal betaling aan van €500.000 vanwege het verkrijgen van toestemming van de bevoegde autoriteiten in Servië om te starten met de afname, verwerking en opslag van navelstrengweefsel.

read more